Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
REGEnLIFE tests light stimulation on neurodegenerative diseases
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases

15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference

15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference

Guillaume Blivet, Aroa Relano-Gines, Mélanie Wachtel, Jacques Touchon.

Share this article